FRANCES ESTRADA: Open Payments
NPI 1831584713 · FAIR LAWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,956 in 38 payments from 9 companies in 2025. Trend: 2023 $259 · 2024 $1,235 · 2025 $1,956
Food & beverage: $1,956
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $569 |
| Neurocrine BioSciences, Inc. | 5 | $286 |
| Vanda Pharmaceuticals Inc. | 2 | $244 |
| AstraZeneca Pharmaceuticals LP | 2 | $231 |
| Alkermes, Inc. | 2 | $143 |
| Otsuka America Pharmaceutical, Inc. | 2 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $117 |
| Teva Pharmaceuticals USA, Inc. | 1 | $109 |
Products named: VRAYLAR, INGREZZA, FANAPT, LYBALVI, REXULTI, AIRSUPRA, CAPLYTA, Auvelity.
Industry payments across NJ — which companies pay providers there.
